Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Prepaid Assets (2016 - 2025)

Heron Therapeutics' Prepaid Assets history spans 14 years, with the latest figure at $9.1 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 48.55% year-over-year to $9.1 million; the TTM value through Dec 2025 reached $9.1 million, down 48.55%, while the annual FY2025 figure was $9.1 million, 48.55% down from the prior year.
  • Prepaid Assets reached $9.1 million in Q4 2025 per HRTX's latest filing, down from $22.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $27.6 million in Q3 2021 to a low of $6.1 million in Q4 2023.
  • Average Prepaid Assets over 5 years is $14.7 million, with a median of $13.0 million recorded in 2021.
  • Peak YoY movement for Prepaid Assets: plummeted 72.4% in 2022, then skyrocketed 302.4% in 2025.
  • A 5-year view of Prepaid Assets shows it stood at $13.0 million in 2021, then increased by 7.71% to $14.0 million in 2022, then tumbled by 56.18% to $6.1 million in 2023, then skyrocketed by 189.15% to $17.7 million in 2024, then tumbled by 48.55% to $9.1 million in 2025.
  • Per Business Quant, the three most recent readings for HRTX's Prepaid Assets are $9.1 million (Q4 2025), $22.8 million (Q3 2025), and $17.4 million (Q2 2025).